Esperance alliance with MD Anderson Cancer Center could accelerate use of anti-cancer drug

    By
    -

    Baton Rouge-based Esperance Pharmaceuticals Inc. has entered into a strategic alliance agreement with MD Anderson Cancer Center to accelerate the clinical development of its lead anti-cancer drug EP-1…


    Already an INSIDER? Sign in.